RMC-4529 is a potent and selective mTOR kinase inhibitor, demonstrating an IC50 of 1.0 nM against phospho-4E-BP1 (T37/46) in cellular assays. This small molecule is a valuable research tool for studying mTOR signaling in cancer and metabolic diseases, applicable in both in vitro and in vivo experimental models.
Molekulargewicht:
1771.17
CAS Nummer:
[2250059-27-7]
Formel:
C90H139N13O23
Target-Kategorie:
mTOR,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten